INTERNATIONAL PATENT: SHANGHAI RNACURE BIOPHARMA CO., LTD., 上海蓝鹊生物医药有限公司 FILES APPLICATION FOR "VZV ANTIGEN VARIANT, NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND USE THEREOF"

GENEVA, June 2 -- SHANGHAI RNACURE BIOPHARMA CO., LTD. (Room 103-287, No. 2, 99 South Changjiang RoadBaoshan District, Shanghai 201906), 上海蓝鹊生物医药有限公司 (中国上海市宝山区长江南路99弄2号103室-287) filed a patent application (PCT/CN2024/133211) for "VZV ANTIGEN VARIANT, NUCLEIC ACID, PHARMACEUTICAL COMPOSITION AND USE THEREOF" on Nov 20, 2024. With publication no. WO/2025/108306, the details related to the patent application was published on May 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is manag...